Recipharm’s $11.4 Million Investment in Nichepharm Lifesciences

Khaitan & Co advised Nichepharm Lifesciences Private Limited and the Sobti Family in the transaction. Recipharm has entered a partnership with Sobti to create production capacity…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here